The University of Southampton
University of Southampton Institutional Repository

Animal models of asthma: value, limitations and opportunities for alternative approaches

Animal models of asthma: value, limitations and opportunities for alternative approaches
Animal models of asthma: value, limitations and opportunities for alternative approaches
Asthma remains an area of considerable unmet medical need. Few new drugs have made it to the clinic during the past 50 years, with many that perform well in preclinical animal models of asthma, failing in humans owing to lack of safety and efficacy. The failure to translate promising drug candidates from animal models to humans has led to questions about the utility of in vivo studies and to demand for more predictive models and tools based on the latest technologies. Following a workshop with experts from academia and the pharmaceutical industry, we suggest here a disease modelling framework designed to better understand human asthma, and accelerate the development of safe and efficacious new asthma drugs that go beyond symptomatic relief.
1359-6446
659-670
Holmes, Anthony M
fb0c6a4b-703f-43bd-a2aa-4c8d8298bc5b
Solari, Roberto
5afc272f-dd7e-4f4a-b046-3758c9bbfaad
Holgate, Stephen T.
2e7c17a9-6796-436e-8772-1fe6d2ac5edc
Holmes, Anthony M
fb0c6a4b-703f-43bd-a2aa-4c8d8298bc5b
Solari, Roberto
5afc272f-dd7e-4f4a-b046-3758c9bbfaad
Holgate, Stephen T.
2e7c17a9-6796-436e-8772-1fe6d2ac5edc

Holmes, Anthony M, Solari, Roberto and Holgate, Stephen T. (2011) Animal models of asthma: value, limitations and opportunities for alternative approaches. Drug Discovery Today, 16 (15-16), 659-670. (doi:10.1016/j.drudis.2011.05.014). (PMID:21723955)

Record type: Article

Abstract

Asthma remains an area of considerable unmet medical need. Few new drugs have made it to the clinic during the past 50 years, with many that perform well in preclinical animal models of asthma, failing in humans owing to lack of safety and efficacy. The failure to translate promising drug candidates from animal models to humans has led to questions about the utility of in vivo studies and to demand for more predictive models and tools based on the latest technologies. Following a workshop with experts from academia and the pharmaceutical industry, we suggest here a disease modelling framework designed to better understand human asthma, and accelerate the development of safe and efficacious new asthma drugs that go beyond symptomatic relief.

This record has no associated files available for download.

More information

Published date: 23 June 2011
Organisations: Clinical & Experimental Sciences

Identifiers

Local EPrints ID: 194685
URI: http://eprints.soton.ac.uk/id/eprint/194685
ISSN: 1359-6446
PURE UUID: dada40d7-28ee-4e93-a496-6246d180d31d

Catalogue record

Date deposited: 09 Aug 2011 14:27
Last modified: 14 Mar 2024 04:00

Export record

Altmetrics

Contributors

Author: Anthony M Holmes
Author: Roberto Solari

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×